Evidence map›Paper›PMID 38871701›Full record

ArticleNature communications2024

Potential pandemic risk of circulating swine H1N2 influenza viruses.

Valerie Le Sage, Nicole C Rockey, Andrea J French, Ryan McBride, Kevin R McCarthy, Lora H Rigatti, Meredith J Shephard, Jennifer E Jones, Sydney G Walter, Joshua D Doyle and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Fatal Human H3N8 Influenza Virus has a Moderate Pandemic Risk.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Valerie Le SageDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Nicole C RockeyDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Andrea J FrenchDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ryan McBrideDepartments of Molecular Medicine and Immunology & Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Kevin R McCarthyDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-1016-6015
Lora H RigattiDivision of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, PA, USA.
Meredith J ShephardDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Jennifer E JonesDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-9970-1063
Sydney G WalterDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Joshua D DoyleCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Lingqing XuCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Dominique J BarbeauCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-6493-5022
Shengyang WangDepartments of Molecular Medicine and Immunology & Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Sheila A FrizzellDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Michael M MyerburgDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
James C PaulsonDepartments of Molecular Medicine and Immunology & Microbiology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-4589-5322
Anita K McElroyCenter for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-6764-7536
Tavis K AndersonVirus and Prion Research Unit, National Animal Disease Center, USDA-ARS, Ames, IA, USA.
Amy L Vincent BakerVirus and Prion Research Unit, National Animal Disease Center, USDA-ARS, Ames, IA, USA.
Seema S LakdawalaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. seema.s.lakdawala@emory.edu.ORCID http://orcid.org/0000-0002-7679-2150

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
Influenza virus receptors on human airway epithelial cellsR01AI114730 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI PAULSON, JAMES C · 2015 to 2023
$5.1M
Role of preexisting immunity on airborne transmission of influenza virusesR01AI158484 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Seema S. Lakdawala · 2022 to 2026
$3.3M
University of Pittsburgh Training Program in Antimicrobial ResistanceT32AI138954 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARRISON, LEE H · 2019 to 2023
$971k
Burroughs Wellcome Fund (BWF) CAMS 1013362.02NIAID NIH HHS 75N93021C00015NIAID NIH HHS R01 AI114730NIAID NIH HHS R01 AI158484NIAID NIH HHS T32 AI138954United States Department of Agriculture | Agricultural Research Service (USDA Agricultural Research Service) 5030-32000-231-000-D
6 · The paper itself

Abstract

Influenza A viruses in swine have considerable genetic diversity and continue to pose a pandemic threat to humans due to a potential lack of population level immunity. Here we describe a pipeline to characterize and triage influenza viruses for their pandemic risk and examine the pandemic potential of two widespread swine origin viruses. Our analysis reveals that a panel of human sera collected from healthy adults in 2020 has no cross-reactive neutralizing antibodies against a α-H1 clade strain (α-swH1N2) but do against a γ-H1 clade strain. The α-swH1N2 virus replicates efficiently in human airway cultures and exhibits phenotypic signatures similar to the human H1N1 pandemic strain from 2009 (H1N1pdm09). Furthermore, α-swH1N2 is capable of efficient airborne transmission to both naïve ferrets and ferrets with prior seasonal influenza immunity. Ferrets with H1N1pdm09 pre-existing immunity show reduced α-swH1N2 viral shedding and less severe disease signs. Despite this, H1N1pdm09-immune ferrets that became infected via the air can still onward transmit α-swH1N2 with an efficiency of 50%. These results indicate that this α-swH1N2 strain has a higher pandemic potential, but a moderate level of impact since there is reduced replication fitness and pathology in animals with prior immunity.

Indexed as

FerretsInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H1N2 SubtypeInfluenza, HumanOrthomyxoviridae InfectionsPandemicsAdultAnimalsAntibodies, NeutralizingAntibodies, ViralFemaleHumansMaleSwineSwine DiseasesVirus ReplicationAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID38871701
PMCPMC11176300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.